Dec 19, 2025 07:45AM
Dec 19, 2025 07:45AM
Jan 14, 2025 04:58AM
Jun 5, 2024 07:00AM
Nov 7, 2022 07:00AM
Jun 8, 2022 07:00AM
Apr 13, 2022 06:37AM UPDATE: Goldman Sachs Reinstates Amicus Therapeutics (FOLD) at Neutral
Sep 29, 2021 06:32AM
May 28, 2021 07:00AM
May 10, 2021 03:38PM
Jun 4, 2020 07:00AM
Jun 4, 2019 04:01PM
Jun 3, 2019 07:00AM
May 31, 2019 05:52AM Amicus Therapeutics (FOLD) Prices 16.279M Share Common Offering at $10.75/Sh
May 30, 2019 09:00PM
May 30, 2019 09:30AM
May 29, 2019 05:41PM
May 29, 2019 04:16PM
May 29, 2019 04:14PM
Apr 5, 2019 09:31AM
Jun 1, 2018 07:00AM Amicus Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference
Feb 21, 2018 04:30PM
Feb 16, 2018 05:43AM
Feb 15, 2018 07:00PM
Feb 14, 2018 04:02PM
Feb 14, 2018 04:01PM
Oct 6, 2017 10:05AM
Jul 18, 2017 07:30AM Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jul 13, 2017 05:47AM
Jul 12, 2017 08:00PM
Jul 12, 2017 04:02PM
Jul 12, 2017 04:01PM
Jun 7, 2017 07:30AM
Jun 1, 2016 07:30AM
May 18, 2016 10:22AM Notable Analyst Rating Changes 5/18: (TSLA) (EQR) (PLCE) Upgraded; (SNI) (XCOM) (ANAC) Downgraded
Apr 12, 2016 09:16AM
Mar 30, 2016 06:38AM
Nov 12, 2015 04:00PM
Oct 5, 2015 10:24AM
Sep 16, 2015 10:32AM

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All